🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Phase 3 study to evaluate the efficacy and safety of birtamimab plus stan...
Status
Terminated
Location
Yale Cancer Center
Start Date
2021-08-30
Trial ID
NCT04973137
Treatments Being Tested
The objective of this study is to evaluate the long-term safety and efficac...
Status
Terminated
Location
City of Hope
Start Date
2017-06-14
Trial ID
NCT03154047
Treatments Being Tested
This is a multicenter, Phase 2b, randomized, double-blind, placebo-controll...
Status
Terminated
Location
Mayo Clinic- Arizona
Start Date
2017-07-05
Trial ID
NCT03168906
This is a global, multicenter, Phase 2b, randomized, double-blind, placebo-...
Status
Completed
Location
City of Hope
Start Date
2016-03
Trial ID
NCT02632786
This is a multi-center, international, randomized, double-blind, placebo-co...
Status
Terminated
Location
Mayo Clinic Arizona
Start Date
2015-02
Trial ID
NCT02312206
Dose escalation study to determine the maximum tolerated dose of NEOD001 in...
Status
Completed
Location
Stanford University Cancer Center
Start Date
2013-04
Trial ID
NCT01707264
Treatments Being Tested
The rationale for this study is to provide additional treatment with NEOD00...
Status
Terminated
Location
Stanford Cancer Institute (SCI)
Start Date
2016-02
Trial ID
NCT02613182
Treatments Being Tested